Astier Demarest

THE LATEST FROM ASTIER DEMAREST

Check our news updates regularly.

DRT : Shareholding reorganization

Ardian enters into exclusivity to become majority shareholder of DRT alongside founding...
Updated 30/11/2017 - Read more >>

Astier Demarest joins GRASSE EXPERTISE®

Contributing to the improvement and influence of the Grasse region know-how ...
Updated 28/11/2017 - Read more >>

Cardamom market report

October review ...
Updated 27/10/2017 - Read more >>

OUR PARTNERS

To promote our partners and their specific capacities is also our role. We echo their current activity.

TRIPPER, INDONESIA
A responsible partner at the origin
“  Strategic partner of Astier Demarest at origin, Tripper is dedicated to provide clean, safe and traceable products, consistent... ”
Read more >>
CHAUDHARY BIOSYS, NEPAL
A collaborative project
“  Nepal, and the Himalayas in particular, are remarkable for their richness of biodiversity. There are an estimated 7,000... ”
Read more >>
DRT, FRANCE
In the heart of pine
“  Established on three production sites in Landes, DRT (Resin and Terpenic Derivatives) in 1932 began development and marketing... ”
Read more >>
All of our partners

Home > Our news


NEWS : DRT announces its acquisition of Société Béarnaise de Synthèse from PCAS

Updated : 10/04/2013

DRT, a specialist since 1932 of the valorisation of rosin and turpentine extracted from pine resin, today announced its acquisition of Société Béarnaise de Synthèse (SBS), a company specialized in acrolein-based synthesis intermediates.

Based in Mourenx (Pyrénées-Atlantiques) on the SOBEGI site, SBS produces acrolein derivatives used in fragrances, pharmaceuticals and fine chemicals. SBS employs 12 people at its production plant (6,000 tons capacity on a 10,000 m² site). The company reported net sales of €3.2 million for 2012 and is now the only firm in Europe whose expertise covers the entire acrolein process for these here above applications. SBS today becomes a wholly owned subsidiary of DRT.
DRT's acquisition of SBS guarantees users of acrolein derivatives, in particular for fragrances, not only a choice of supplier but also the certainty working with Mourenx plant that drastic conditions impose by production, handling and transport of these products will be fully respected.
The acquisition also expands DRT's portfolio of ingredients for the fragrance sector and adds a new area of know-how that opens the door to new markets (pharmaceuticals, industry, etc.).
"We saw this acquisition as a real opportunity on two counts," explains Laurent Labatut, Chairman and CEO, DRT. "First of all, by taking over SBS, DRT is saving 12 jobs and keeping a unique body of know-how in France; it also opens up new prospects for the Group to ensure our continued development over the long term," he added.

ALL OUR NEWS :